Connecticut joins New York, Minnesota, and many other states by considering SB 270, a bill that seeks to limit physician-pharmaceutical industry interaction. During a debate in late February in a Public Health Committee hearing for the Connecticut General Assembly, the
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments
